Recent Quotes (30 days)

You have no recent quotes
chg | %

Aurora Cannabis Inc  

(Public, CVE:ACB)   Watch this stock  
Find more results for ACB
2.58
+0.06 (2.38%)
Apr 28 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.51 - 2.65
52 week 1.56 - 3.95
Open 2.52
Vol / Avg. 1.83M/4.23M
Mkt cap 795.49M
P/E     -
Div/yield     -
EPS -0.08
Shares 319.34M
Beta     -
Inst. own     -
May 29, 2017
Q3 2017 Aurora Cannabis Inc Earnings Release (Estimated) Add to calendar
Feb 27, 2017
Q2 2017 Aurora Cannabis Inc Earnings Release
  

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin -68.94% -397.67%
Operating margin -61.17% -318.96%
EBITD margin - -486.47%
Return on average assets -13.86% -35.86%
Return on average equity -18.53% -116.87%
CDP Score - -

Address

Suite 1500, 1199 West Hastings Street
VANCOUVER, BC V6E 3T5
Canada
+1-604-3625207 (Phone)
+1-604-6699768 (Fax)

Website links

Description

Aurora Cannabis Inc, formerly Prescient Mining Corp, is a Canada-based company, which is in the business of producing and distributing medical marijuana pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company’s primary business consists of the sale of dried medical cannabis. The Company’s principal market is patients who use medical cannabis in Canada. It operates under the following segments: the production and sale of medical cannabis, as well as patient counseling and outreach services. The Company sells dried medical cannabis by direct delivery to patients through physical delivery services, as well as ordering services through the phone and the Company’s online shop and mobile application. The Company operates its business through its subsidiaries: Aurora Marijuana Inc, Aurora Cannabis Enterprises Inc, 1769474 Alberta Ltd, Australis Capital Inc, CanvasRx Inc and 10094595 Canada Inc.

Officers and directors

Steve Dobler President, Director
Terry Booth Chief Executive Officer, Director
Amy Stephenson Interim Chief Financial Officer
Cam Battley Executive Vice President
Neil Belot Chief Global Business Development Officer
Barry Waisglass Medical Director
Nilda Rivera Corporate Secretary
Joseph Del Moral Director
Jason Dyck Ph.D. Director
Charles Rifici Director